Surgery + Radiation
“Coordinated care, clear cost guidance and compassionate follow‑ups made a tough journey feel structured and hopeful.”
Personalized blood cancer care by leading oncologists in Delhi. Rapid diagnosis, second opinions & compassionate support.
Consult with our curated leading experts of Blood Cancer treatment & get an instant consultation.

Surgical Oncologist
Mumbai, India
Breast oncology and minimally invasive specialist.

Radiation Oncologist
Delhi NCR, India
Precision IMRT for prostate and head & neck.

Hematologist
Bangalore, India
BMT and complex leukemia care.

Medical Oncologist
Chennai, India
Targeted and immunotherapy planning.

Surgical Oncologist
Hyderabad, India
Robotic GI cancer surgery.

Radiation Oncologist
Pune, India
SBRT and head & neck protocols.
Expert guidance, priority access, and coordinated care—built around you.
We handpick specialists based on multiple factors to provide the best possible care.
Thousands of patients trust us for confident treatment decisions.
Book with our experts and get priority—online or in‑hospital.
Doctors trained at top cancer centers like AIIMS, TMC, RGCIH and others.
Oncology, cardiology, nephrology, neurology, psychology and more—working together.
We match you to the right expert for your diagnosis and priorities.
Real experiences from Indian patients & caregivers navigating multidisciplinary cancer care.
Surgery + Radiation
“Coordinated care, clear cost guidance and compassionate follow‑ups made a tough journey feel structured and hopeful.”
Chemotherapy
“Streamlined appointments, quick second opinions and transparent estimates reduced our anxiety significantly.”
Endocrine Therapy
“Nutritional guidance & rehabilitation tracking helped me recover strength faster after completing therapy.”
Targeted Therapy
“Cost breakdowns were precise; I could plan insurance claims and avoid surprise expenses.”
Follow‑up Care
“Doctor selection filters saved time. Remote updates kept extended family informed without chaos.”
Chemotherapy + Supportive Care
“Personalized staging explanation and therapy pathway boosted my confidence before starting cycles.”
Surgery + Radiation
“Coordinated care, clear cost guidance and compassionate follow‑ups made a tough journey feel structured and hopeful.”
Chemotherapy
“Streamlined appointments, quick second opinions and transparent estimates reduced our anxiety significantly.”
Endocrine Therapy
“Nutritional guidance & rehabilitation tracking helped me recover strength faster after completing therapy.”
Targeted Therapy
“Cost breakdowns were precise; I could plan insurance claims and avoid surprise expenses.”
Follow‑up Care
“Doctor selection filters saved time. Remote updates kept extended family informed without chaos.”
Chemotherapy + Supportive Care
“Personalized staging explanation and therapy pathway boosted my confidence before starting cycles.”
Real work. Real impact. Embedded education & innovation content—watch videos, explore research, and see how BigOHealth advances cancer care.
Video
Video
Video
Video
Video
ConferenceLeading oncologists discuss breakthrough treatments and future of cancer care.
ConferenceCommunity workshop on breast cancer prevention, detection, and treatment options.
Tell us your situation and we’ll match you with the right cancer specialist in your city.
Quick call. No obligation.
Umbrella term for hematologic malignancies: leukemia (AML/ALL/CML/CLL), lymphoma (Hodgkin/Non‑Hodgkin) and multiple myeloma. Diagnosis uses blood counts, marrow biopsy, flow cytometry and genetic testing.
Blood cancers arise from bone marrow and lymphatic tissues. Leukemias involve abnormal white cells; lymphomas involve lymph nodes and extranodal sites; myeloma arises from plasma cells. Modern care combines risk‑adapted chemotherapy, targeted/immune therapy and stem cell transplantation with strong infection prevention and supportive care.
Global Incidence: ≈1.3M hematologic malignancies/year worldwide (combined)
India Incidence: Increasing recognition; pediatric ALL common, adult AML/CLL/CML prevalent; myeloma rising with aging
Prevalence: Hodgkin/Non‑Hodgkin lymphoma and myeloma form major adult burdens
Avg Diagnosis Age: Varies: pediatric ALL ~4–10y; AML ~65y; CLL/CML/myeloma typically >60y
Overall Survival: Highly subtype & risk dependent; targeted therapy improves outcomes
Survival ranges reflect population data; individual prognosis depends on stage, biology, and access to multidisciplinary care.
Management is subtype‑specific and risk‑stratified (ELN/WHO for AML, Ph+ ALL/CML BCR‑ABL, IPI/Ann Arbor for lymphomas, R‑ISS for myeloma). Decisions integrate molecular markers (FLT3/NPM1, BCR‑ABL, TP53, BTK, MYD88), age/fitness, organ function, and minimal residual disease (MRD).
Driver mutations, chromosomal translocations and epigenetic changes disrupt maturation and survival pathways (e.g., BCR‑ABL tyrosine kinase in CML, FLT3 in AML, t(11;14)/MYC in lymphoma, IgH translocations in myeloma). Microenvironmental signals (cytokines, stromal support) maintain disease.
Red flags: persistent fatigue/pallor, easy bruising/bleeding, recurrent infections, lymph node swelling, bone pain/back pain, night sweats, fever, weight loss. CBC with differential, peripheral smear, LDH, serum protein electrophoresis (myeloma), and timely marrow biopsy expedite diagnosis.
Leukemia: induction/consolidation ± maintenance; TKIs for BCR‑ABL; venetoclax/hypomethylating agents in unfit AML; allogeneic HSCT for high‑risk. Lymphoma: chemo‑immunotherapy (e.g., R‑CHOP), RT for select sites, BTK inhibitors in relapse, CAR‑T in refractory. Myeloma: triplet regimens (PI + IMiD + steroid), autologous transplant, bone protection, and maintenance (lenalidomide).
Focus on infection prevention/vaccination, fertility counseling, cardiac monitoring (anthracyclines), neuropathy management (taxanes/PI), bone health (bisphosphonates), psychosocial support, and surveillance for relapse or second malignancies.
Individualized care aligns tumor biology, stage, and patient goals to optimize outcomes.
Unified, compact view of symptom clusters and treatment impact. Content remains fully visible for search engines; search gently highlights matching terminology.
Early, common & advanced signs of blood cancer

Short & long-term side effects of blood cancer treatment
Informational reference only; seek urgent care for severe or rapidly worsening symptoms.
Transparent, patient-centered cost guidance for planning informed care decisions. Indicative INR ranges; costs vary by subtype, hospital, complications, and individualized treatment pathways.
N/A
N/A
N/A
Disclaimer: Indicative estimates only. Individual plans depend on clinical staging, biology & personalization.
Get comprehensive cancer treatment opinions from a team of specialized oncologists - all in one place. Our virtual tumor board brings together medical, radiation, surgical, and nuclear medicine experts for your personalized care plan.
Clear, patient‑friendly answers to common blood cancer queries. All FAQs are visible (no accordion) for easy scanning and search optimization.
Blood cancer symptoms often include severe tiredness, frequent infections, unexplained fever, and sudden weight loss. Some people notice easy bruising, bleeding, or night sweats. Swollen lymph nodes may also appear as an early warning sign.
Important signs of blood cancer are pale skin, weakness, bone or joint pain, repeated fevers, and unusual bleeding like nosebleeds or gum bleeding. Lumps in the neck, armpit, or groin can also indicate a problem. Symptoms that last for weeks should be checked by a doctor.
Blood cancer develops when the blood-forming cells start multiplying abnormally. This can happen due to genetic mutations, exposure to chemicals, radiation, smoking, or weak immunity. In many cases, the exact reason remains unknown.
Yes, many blood cancers can be treated effectively, and some can be cured with the right therapy. Treatments include chemotherapy, immunotherapy, targeted drugs, and bone marrow transplant. Outcomes are better when the cancer is diagnosed early.
A Complete Blood Count (CBC) is the first test used to detect unusual blood cells. If cancer is suspected, doctors may advise bone marrow biopsy, flow cytometry, or genetic tests for confirmation. These tests help identify the exact type and stage.
The major blood cancer types are Leukemia, Lymphoma, and Myeloma. Each type affects different cells of the blood and immune system. Understanding the type helps doctors choose the best treatment plan.
Educational guidance only; consult qualified oncology professionals for personalized medical advice.